- 95% of approximately 7,000 rare diseases have yet to find treatments
Empowering patients and researchers with AI- powered rare disease drug matching
RareGeno connects the data of rare diseases with researchers and drug developers to enable personalized diagnosis, treatment, and research
We are fully integrated with the following disease data networks
How we innovate?
The RareGeno Approach
Our innovative approaches allow us to unlock possible solutions for patients with rare diseases
How it works?
Helping find novel compounds or combinations
RareGeno helps research organizations and pharmaceutical companies use our AI technology to process their data and discover novel compounds and combinations
Launching in Canada soon
1 in 12 Canadians
live with rare diseases
The time is now! With a national approach to improve treatment for rare diseases, we aim to play the pivotal role to help your initiatives get results
Canadian Organization for Rare Disorders
CORD is Canada's national network for organizations representing all those with rare disorders.
CIHR Rare Disease Research Initiative
Supporting the establishment of a robust national rare disease clinical trials network as well as preclinical and implementation research.
Implementation Advisory Group (IAG)
The Implementation Advisory Group is a cross section of the rare disease experience, including patients and clinicians, private drug plans, and the pharmaceutical industry.
Care4Rare Canada
A collaborative team of clinicians, bioinformaticians, scientists, and researchers, focused on improving the diagnostic care of Rare Genetic Disease patients